Previous 10 | Next 10 |
Earnings remained a key driver in Thursday's midday action. ViacomCBS (NASDAQ:VIAC) and STAAR Surgical (NASDAQ:STAA) both posted notable gains in intraday action, as investors reacted positively to new financial figures. Meanwhile, several big names suffered declines in the aftermath of their...
Gainers: Profound Medical (NASDAQ:PROF) +28%, STAAR Surgical (NASDAQ:STAA) +19%, AdaptHealth (NASDAQ:AHCO) +17%, Flora Growth (NASDAQ:FLGC) +16%, Invacare (NYSE:IVC) +15%. Losers: Inogen (NASDAQ:INGN) -32%, Karyopharm Therapeutics (NASDAQ:KPTI) ...
Image source: The Motley Fool. STAAR Surgical Company (NASDAQ: STAA) Q2 2021 Earnings Call Aug 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: STAAR Surgical Company (STAA) Q2 2021 Earnings Call Transcript
STAAR Surgical Company (STAA) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants Brian Moore – Vice President, Investor, Media Relations and Corporate Development Caren Mason – President and Chief Executive Officer Patrick Williams – Chief Fin...
STAAR Surgical (NASDAQ:STAA): Q2 Non-GAAP EPS of $0.18 beats by $0.09; GAAP EPS of $0.17 beats by $0.14. Revenue of $62.4M (+77.3% Y/Y) beats by $9.79M. Press Release For further details see: STAAR Surgical EPS beats by $0.09, beats on revenue
Second Quarter ICL Sales Up 93% Y/Y and Units Up 79% Y/Y Increases Full Year 2021 Net Sales Outlook to Range of $227 Million to $230 Million STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion deli...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the second quarter ended July 2, 2021 on Wednesday, August 4, 20...
P_Wei/E+ via Getty Images Clear aligners manufacturers sized up at Stephens Align Technology (ALGN) has added ~1.3% in the pre-market after Stephen upgraded the stock to overweight as a recent analysis of Invisalign App data prompted the firm to conclude a favorable outlook for the ...
STAAR Surgical (NASDAQ: STAA) stock is up more than 243% over the past 12 months and more than 85% this year. The company has had an explosive year financially. Now, investors are willing to go all in on the company's technology, which supports a new type of corrective vision surger...
Warren Buffett's timeless approach to picking stocks is something that every investor should know. With his focus on traits like financial consistency and sustainable competitive advantages, Buffett's strategy is proven effective, and it also has a consistent internal logic that's both eleg...
News, Short Squeeze, Breakout and More Instantly...
STAAR Surgical Company Company Name:
STAA Stock Symbol:
NASDAQ Market:
STAAR Surgical Company Website:
2024-07-14 17:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Will...
2024-05-24 07:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...